BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9264565)

  • 1. Involvement of annexin V in antiproliferative effects of gonadotropin-releasing hormone agonists on human endometrial cancer cell line.
    Shibata S; Sato H; Ota H; Karube A; Takahashi O; Tanaka T
    Gynecol Oncol; 1997 Aug; 66(2):217-21. PubMed ID: 9264565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of annexin V in the antiproliferative effect of GnRH agonist on cultured human uterine leiomyoma cells.
    Yamamoto H; Sato H; Shibata S; Murata M; Fukuda J; Tanaka T
    Mol Hum Reprod; 2001 Feb; 7(2):169-73. PubMed ID: 11160843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gonadotropin-releasing hormone analogs and their conjugates on gonadotropin-releasing hormone receptor--positive human cancer cell lines.
    Pályi I; Vincze B; Kálnay A; Turi G; Mezõ I; Teplán I; Seprõdi J; Pató J; Móra M
    Cancer Detect Prev; 1996; 20(2):146-52. PubMed ID: 8706040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
    Borri P; Coronnello M; Noci I; Pesciullesi A; Peri A; Caligiani R; Maggi M; Torricelli F; Scarselli G; Chieffi O; Mazzei T; Mini E
    Gynecol Oncol; 1998 Dec; 71(3):396-403. PubMed ID: 9887238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist inhibits human telomerase reverse transcriptase mRNA expression in endometrial cancer cells.
    Nagai N; Oshita T; Mukai K; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2002 Nov; 10(5):593-7. PubMed ID: 12373298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide).
    Kakar SS
    Cancer Res; 1998 Oct; 58(20):4558-60. PubMed ID: 9788600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist Buserelin affects colony-forming efficiency of HHUA and Jurkat cells.
    Enomoto M; Mori T; Park MK
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1180-7. PubMed ID: 11741317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone.
    Enomoto M; Seong JY; Kawashima S; Park MK
    Life Sci; 2004 May; 74(25):3141-52. PubMed ID: 15081579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of apoptosis by gonadotrophin-releasing hormone agonist in cultures of endometrial cells from women with symptomatic myomas.
    Kang JL; Wang DY; Wang XX; Yu J
    Hum Reprod; 2010 Sep; 25(9):2270-5. PubMed ID: 20634188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signalling and anti-proliferative effects mediated by gonadotrophin-releasing hormone receptors after expression in prostate cancer cells using recombinant adenovirus.
    Franklin J; Hislop J; Flynn A; McArdle CA
    J Endocrinol; 2003 Feb; 176(2):275-84. PubMed ID: 12553876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death.
    Imai A; Takagi A; Horibe S; Takagi H; Tamaya T
    J Clin Endocrinol Metab; 1998 Feb; 83(2):427-31. PubMed ID: 9467552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of monocyte chemotactic protein-1 in human endometrial cancer cells and the effect of treatment with tamoxifen or buserelin.
    Wang L; Zheng W; Zhang S; Chen X; Hornung D
    J Int Med Res; 2006; 34(3):284-90. PubMed ID: 16866022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
    Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
    J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
    Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
    J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.